Glucotrack selects cirtec medical as manufacturer for its implantable continuous blood glucose monitor

Rutherford, nj & brooklyn park, mn, feb. 27, 2024 (globe newswire) -- glucotrack, inc. (nasdaq: gctk), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced the selection of cirtec medical corp, the leading medical device solutions provider of implantable therapies, as manufacturer for the implantable continuous blood glucose monitor (cbgm). the two companies have signed a development agreement for clinical and commercial manufacturing.
GCTK Ratings Summary
GCTK Quant Ranking